ClinicalTrials.Veeva

Menu

Effect of Some Drugs on Rheumatoid Arithritis Activity

S

Sherief Abd-Elsalam

Status and phase

Enrolling
Phase 3

Conditions

Rheumatoid Arthritis

Treatments

Drug: Montelukast
Drug: Rupatadine

Study type

Interventional

Funder types

Other

Identifiers

NCT03770923
Rheumatoid Arithritis

Details and patient eligibility

About

Effect of Some Drugs on Rheumatoid Arithritis Activity.

Full description

The study aims at evaluating the effect of Some Drugs on Rheumatoid Arithritis Activity.

Enrollment

75 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Rheumatoid arthritis

Exclusion criteria

  • liver or renal disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

75 participants in 3 patient groups

No intervention
No Intervention group
Description:
No intervention
Rupatadine
Active Comparator group
Description:
Rupatadine 10 mg once daily.
Treatment:
Drug: Rupatadine
Montelukast
Active Comparator group
Description:
Montelukast 10 mg daily
Treatment:
Drug: Montelukast

Trial contacts and locations

1

Loading...

Central trial contact

Sherief Abd-Elsalam, Ph D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems